Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells

Alexandre de la Taille1, Mark A Rubin, Min-Wei Chen

  • 1Department of Urology, Assistance Publique des Hôpitaux de Paris-CHU Mondor, 94000 Créteil, France. adelataille@hotmail.com

Abstract

Insights

Abnormal beta-catenin expression and localization are linked to prostate cancer progression, particularly to a therapy-resistant state. These findings highlight beta-catenin

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Beta-catenin is a key protein in the Wnt signaling pathway, regulating cell growth and behavior.
  • Dysregulation of beta-catenin is implicated in various cancers, including prostate cancer.

Purpose of the Study:

  • To investigate beta-catenin expression, localization, and activity in prostate cancer.
  • To evaluate these changes in an in vitro model of acquired apoptosis resistance and in primary prostate tumors.

Main Methods:

  • Derived apoptosis-resistant prostate cancer cell lines from parental LNCaP cells.
  • Analyzed beta-catenin expression and localization using Western blotting and cell fractionation.
  • Assessed transcriptional activity using a beta-catenin-sensitive reporter plasmid.
  • Evaluated beta-catenin in 212 primary prostate cancer specimens via immunohistochemistry.

Main Results:

  • Apoptosis-resistant cells showed a shift of beta-catenin from membrane to cytoplasmic/nuclear fractions.
  • Transcriptional activity of beta-catenin increased significantly in resistant cells.
  • Nuclear/cytoplasmic beta-catenin correlated with hormone-refractory prostate cancer (HRPC) status and Gleason score.
  • Abnormal beta-catenin in localized prostate cancer was associated with higher Gleason scores and advanced stage.

Conclusions:

  • Anomalies in beta-catenin expression and localization occur in prostate cancer.
  • These anomalies are associated with disease progression, especially the development of therapeutic resistance.

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...